New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches

Aisha A. Alsfouk(Princess Nourah bint Abdulrahman University), Bshra A. Alsfouk(Princess Nourah bint Abdulrahman University), Ashwag S. Alanazi(Princess Nourah bint Abdulrahman University), Najla Altwaijry(Princess Nourah bint Abdulrahman University), Ahlam Sultan(Princess Nourah bint Abdulrahman University), Omkulthom Al kamaly(Princess Nourah bint Abdulrahman University), Hanan M. Alshibl(King Saud University)
Pharmaceuticals
July 18, 2023
10.3390/ph16071018
Cited by 7

Related Papers

A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
|International Journal of Biological Macromolecules|2023|125
Synthesis, in vitro thymidine phosphorylase inhibitory activity and molecular docking study of novel pyridine-derived bis-oxadiazole bearing bis-schiff base derivatives
|Arabian Journal of Chemistry|2023|65
The ProTide Prodrug Technology: Where Next?
|ACS Medicinal Chemistry Letters|2018|58
Molecular modeling and DFT studies on the antioxidant activity of <i>Centaurea scoparia</i> flavonoids and molecular dynamics simulation of their interaction with β-lactoglobulin
|RSC Advances|2023|55
3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists
|Processes|2022|53